Analysts Set Addus HomeCare Corporation (NASDAQ:ADUS) Target Price at $131.00

Addus HomeCare Corporation (NASDAQ:ADUS) has been assigned an average rating of “Moderate Buy” from the ten research firms that are covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell rating, two have given a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company. The average 12 month price target among brokers that have covered the stock in the last year is $131.50.

Several analysts recently weighed in on the stock. Wall Street Zen cut shares of Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research note on Saturday, March 21st. Barclays raised their price objective on Addus HomeCare from $92.00 to $96.00 and gave the stock an “underweight” rating in a research report on Wednesday. Citizens Jmp reiterated a “market outperform” rating and set a $142.00 price target on shares of Addus HomeCare in a report on Monday, May 18th. Finally, Weiss Ratings upgraded Addus HomeCare from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday.

Addus HomeCare Price Performance

ADUS stock traded down $1.51 during mid-day trading on Friday, hitting $108.21. The stock had a trading volume of 220,352 shares, compared to its average volume of 260,281. The firm has a fifty day simple moving average of $96.14 and a 200 day simple moving average of $101.09. The firm has a market capitalization of $2.02 billion, a P/E ratio of 20.00, a P/E/G ratio of 1.48 and a beta of 0.88. The company has a current ratio of 1.83, a quick ratio of 1.83 and a debt-to-equity ratio of 0.08. Addus HomeCare has a 52 week low of $87.95 and a 52 week high of $124.43.

Addus HomeCare (NASDAQ:ADUS) last released its earnings results on Monday, May 4th. The company reported $1.62 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.52 by $0.10. The firm had revenue of $363.50 million for the quarter, compared to analysts’ expectations of $366.41 million. Addus HomeCare had a return on equity of 9.80% and a net margin of 6.89%.The business’s revenue for the quarter was up 7.7% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.42 earnings per share. As a group, research analysts forecast that Addus HomeCare will post 6.24 EPS for the current year.

Insider Activity at Addus HomeCare

In other Addus HomeCare news, insider Heather Brianne Dixon sold 288 shares of the business’s stock in a transaction dated Monday, June 22nd. The shares were sold at an average price of $93.77, for a total value of $27,005.76. Following the transaction, the insider directly owned 44,371 shares in the company, valued at $4,160,668.67. The trade was a 0.64% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders have sold 966 shares of company stock worth $90,168. 4.10% of the stock is owned by company insiders.

Institutional Trading of Addus HomeCare

A number of large investors have recently modified their holdings of ADUS. Assenagon Asset Management S.A. lifted its position in Addus HomeCare by 2.0% in the 2nd quarter. Assenagon Asset Management S.A. now owns 5,905 shares of the company’s stock worth $593,000 after buying an additional 114 shares during the last quarter. City Center Advisors LLC purchased a new stake in shares of Addus HomeCare in the 2nd quarter worth about $301,000. Parallel Advisors LLC grew its holdings in shares of Addus HomeCare by 66.3% during the 1st quarter. Parallel Advisors LLC now owns 404 shares of the company’s stock worth $38,000 after acquiring an additional 161 shares during the period. Argent Capital Management LLC raised its holdings in Addus HomeCare by 56.4% in the first quarter. Argent Capital Management LLC now owns 70,235 shares of the company’s stock worth $6,578,000 after purchasing an additional 25,315 shares in the last quarter. Finally, Bank of America Corp DE increased its stake in shares of Addus HomeCare by 11.3% in the 1st quarter. Bank of America Corp DE now owns 323,037 shares of the company’s stock worth $30,252,000 after acquiring an additional 32,714 shares in the last quarter. Institutional investors own 95.35% of the company’s stock.

Addus HomeCare Company Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.